#United States #Los Angeles #Securities Fraud #Hims & Hers Health #Glancy Prongay Wolke

Investors of Hims & Hers Health, Inc. Have Legal Options

In a significant move for shareholders of Hims & Hers Health, Inc. (HIMS), the law firm Glancy Prongay Wolke & Rotter LLP has announced that individuals who suffered financial losses from their investments have a chance to take the lead in a securities fraud class action lawsuit against the company. This announcement came on October 6, 2026, offering a critical opportunity for investors to reclaim their losses through legal channels.

Background of the Lawsuit

The lawsuit centers around allegations that between August 4, 2025, and July 29, 2026, Hims & Hers Health, Inc. made misleading statements and failed to disclose crucial information regarding its business activities and future prospects. Specifically, the complaint highlights a series of alleged misconducts by the company's management:

1. Unauthorized Sharing of Health Information: The complaint states that Hims & Hers Health shared sensitive consumer health information with third-party advertising platforms, raising significant privacy concerns.
2. Misleading Financial Practices: The company reportedly charged consumers for prescriptions almost immediately after they submitted health intake forms, contradicting claims that they would have time to consult with a medical professional first.
3. Regulatory Scrutiny: These actions likely exposed the company to increased regulatory scrutiny, suggesting potential legal repercussions down the line.
4. Impending Fees and Penalties: The lawsuit claims these practices made the company vulnerable to hefty fees and penalties, undermining earlier positive assertions made by management regarding the company's well-being and growth prospects.

Such allegations reveal that the optimistic view shared by Hims & Hers Health about its stability and future was not backed by solid evidence, leading to a material misrepresentation of its business conditions to shareholders.

Next Steps for Shareholders

Investors who wish to participate in the lawsuit as lead plaintiffs must act swiftly, as the deadline to file is set for November 2, 2026. Those interested can click on the link provided by Glancy Prongay Wolke & Rotter LLP for more information and to discuss their rights regarding this legal matter. Meanwhile, it is important for potential lead plaintiffs to remember that they have the option to retain a legal counsel of their choice to guide them through the process.

If you're a shareholder affected by the alleged misconduct during the defined period, your participation could play a pivotal role in seeking justice and potentially recovering your financial losses. Notably, no class has yet been certified, and individual actions may vary based on the specifics of each investment and loss.

Why Glancy Prongay Wolke & Rotter LLP?

Choosing to work with Glancy Prongay Wolke & Rotter LLP provides shareholders with access to a well-respected law firm known for its success in representing investors in complex securities litigation. The firm has been acknowledged as one of the top securities litigation groups in recent years, with a strong track record of recovering losses for clients. Their expertise spans various industries, ensuring that clients receive informed and dedicated support through each step of the lawsuit.

In closing, Hims & Hers Health, Inc. shareholders with financial losses should take advantage of this opportunity to hold the company accountable for its alleged securities fraud. With the deadline approaching, immediate action is encouraged to ensure your voice is heard as a lead plaintiff in this important case.